Amgen Inc financial statements, FY2006–FY2025
Amgen Inc reported revenue of $36.8B and net income of $7.71B for the fiscal year ended 2025-12-31, as stated in its filing with US SEC EDGAR. Listed as AMGN (Nasdaq). Fiscal year ends 31 December.
FactReportedAnnual figures as reported, in USD, 5 measures over 20 fiscal years. Each value links to the filing it came from. Nothing is restated, annualised, converted or estimated; a period a filing did not state is shown as a gap.
Annual results by fiscal year
| Fiscal year end | Revenue | Operating income | Net income | Total assets | Stockholders' equity |
|---|---|---|---|---|---|
| 2025-12-31 | $36.8B | $9.08B | $7.71B | $90.6B | $8.66B |
| 2024-12-31 | $33.4B | $7.26B | $4.09B | $91.8B | $5.88B |
| 2023-12-31 | $28.2B | $7.9B | $6.72B | $97.2B | $6.23B |
| 2022-12-31 | $26.3B | $9.57B | $6.55B | $65.1B | $3.66B |
| 2021-12-31 | $26B | $7.64B | $5.89B | $61.2B | $6.7B |
| 2020-12-31 | $25.4B | $9.14B | $7.26B | $62.9B | $9.41B |
| 2019-12-31 | $23.4B | $9.67B | $7.84B | $59.7B | $9.67B |
| 2018-12-31 | $23.7B | $10.3B | $8.39B | $66.4B | $12.5B |
| 2017-12-31 | $22.8B | $9.97B | $1.98B | $80B | $25.2B |
| 2016-12-31 | $23B | $9.79B | $7.72B | $77.6B | $29.9B |
| 2015-12-31 | $21.7B | $8.47B | $6.94B | $71.4B | $28.1B |
| 2014-12-31 | $20.1B | $6.19B | $5.16B | $69B | $25.8B |
| 2013-12-31 | $18.7B | $5.87B | $5.08B | $66.1B | $22.1B |
| 2012-12-31 | $17.3B | $5.58B | $4.34B | $54.3B | $19.1B |
| 2011-12-31 | $15.6B | $4.31B | $3.68B | $48.9B | $19B |
| 2010-12-31 | $15.1B | $5.54B | $4.63B | $43.5B | $23.9B |
| 2009-12-31 | $14.6B | $5.51B | $4.61B | $39.6B | $22.7B |
| 2008-12-31 | $15B | $5.21B | $4.05B | $36.4B | $20.9B |
| 2007-12-31 | $14.8B | $3.98B | $3.08B | — | $18.5B |
| 2006-12-31 | — | — | — | — | $19.8B |
About these figures
Every number on this page is a fact with a filing behind it, retrieved from US SEC EDGAR and stored with the period it belongs to. Figures are shown as the company reported them for that period; a later restatement supersedes the earlier value rather than overwriting it. Market capitalisation is not shown anywhere on this site because no licensed price source is used; the profile shows reported public float where a filing states it.